Site-specific mutagenesis was used to modify an amino acid residue of the catalytic trimer of aspartate transcarbamoylase thought to be at the active site. Tyrosine 165 of the catalytic chain was replaced by a serine residue. This mutation substantially reduces but does not entirely abolish the catalytic activity of the holoenzyme and the isolated catalytic trimer. Km for aspartate for the mutant catalytic trimer is 12-fold higher than for the wild type. Vmax is reduced by a factor of 4 and Kd for carbamoylphosphate is increased 3-fold in the mutant. Although these results suggest that tyrosine 165 is at the active site, they demonstrate that the residue is not essential for catalysis.
No takes yet. Share an insight, caveat, or question.
Robey et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: